Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00416533 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: doxorubicin hydrochloride
DRUG: prednisone

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]